The Future of Monoclonal Antibodies - WHITEPAPER
The monoclonal antibodies market continues to grow - according to BIS Research and Research and Markets, monoclonal antibodies (mAbs) are expected to make up just under half of the USD $22.7 billion biologics discovery market in 2025.
This whitepaper looks at the current state and future of monoclonal antibodies, such FDA approvals over 2018 and 2019, emerging trends and how next generation antibody therapeutics will look in the next 10 years.
